Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/04/25

Trade details

Type
Insider sale
Amount
$421,260
Shares · price
1,785 sh · $236.00 a share
Held after
1,409 sh
Trade date
24/04/23
Filed
24/04/25
Days to filing
2 days

Sold 55.9% of holdings

Share of holding sold
55.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/24~24/05/23

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $421.3K of United Therapeutics UTHR · 55.9% of holdings · 10b5-1 plan | Whalegun